Chinese herbal medicine may improve outcomes after STEMI
Descrição
CHICAGO — A drug derived from traditional Chinese medicine as an adjunct to guideline-directed therapy improved CV outcomes at 30 days and 1 year compared with placebo after revascularization, with no excess bleeding risk, a speaker reported.“Despite reperfusion and optimal medical therapy, patients with STEMI still face a high risk of in-hospital mortality, myocardial no-flow and
Signaling pathways and targeted therapy for myocardial infarction
Chinese Herbal Medicine May Offer Benefits in STEMI: CTS-AMI
In acute myocardial infarction patients, does adding a traditional Chinese medicine compound to standard treatments improve outcomes?
Chinese Medicine Tongxinluo Improves STEMI Outcomes, Sparks Debates - Cardiac Wire
New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials - eBioMedicine
Impacts of the hearing aid intervention on healthcare utilization and costs among middle-aged and older adults: results from a randomized controlled trial in rural China - The Lancet Regional Health – Western
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
Frontiers Acceptability of Traditional Chinese Medicine in Chinese People Based on 10-Year's Real World Study With Mutiple Big Data Mining
ACHIEVEMENTS IN CLINICAL RESEARCH OF TREATING INTERNAL DISEASES WITH TRADITIONAL CHINESE MEDICINE IN RECENT YEARS
de
por adulto (o preço varia de acordo com o tamanho do grupo)
